Delos is a formulation platform based on proprietary technology which improves the quality and performance of actives and ingredients. We develop next generation nanomedicines and new delivery systems with tailored and improved properties in terms of bioavailability, stability, addressability, and multifunctionality. We protect and transport from small molecules to proteins and biomolecules, integrating and stabilizing them on solid particles or nanovesicles.
Delos is a green and sustainable platform, that uses compressed CO2 as solvent, that brings efficiently to you new drug formulations based on fine particles and nanoencapsulated actives.
We are a flexible R+D partner and we can tailor projects to our partner’s needs, supporting them throughout all development stages. Our partnering and codevelopment model includes the following stages:
We have developed a new class of Small Unilamellar Vesicles (SUV) for the efficient and versatile integration of small molecules, peptides, proteins, targeting ligands, fluorescent organic molecules and genetic material (DNA, RNA). The main features of the formulations based in this new kind of Delos nanocarriers are the following:
Delos platform permits to reformulate active ingredients as solid particulate materials, with extremely efficient control on their size, morphology, solid form, purity and homogeneity. This platform can supply powdered solid micro and nanoparticles as drug delivery systems and sustained release forms. Pure micronized APIs or pharmaceutical ingredients combining APIs and several excipients, such as polymers or lipids, in form of micron or nano-sized particles can be straightforwardly produced.
As a one-step production of micron-and nanosized particles, Delos brings real advantages over conventional crystallization / precipitation / micronization processes, such as: